🔎 Trials Near Me

Akèy › Kansè Metastatik › Arizona › Phoenix

Etid klinik pou Kansè Metastatik nan Phoenix, AZ

20 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote Phoenix (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Ap rekriteFaz 3
  • City of Hope, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07562152

PRE-ISPY Phase I/II Oncology Platform Program

Ap rekriteFaz 1/2
  • Mayo Clinic Comprehensive Cancer Center, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT05868226

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Ap rekriteFaz 2/3
  • Mayo Clinic Hospital, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Ap rekriteFaz 3
  • Banner MD Anderson Cancer Center, Phoenix
  • Ironwood Cancer & Research Centers, Phoenix
  • Mayo Clinic Building- Phoenix, Phoenix
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Ap rekriteFaz 1
  • Mayo Clinic Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07277413

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Ap rekriteFaz 2/3
  • Mayo Clinic Hospital, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Ap rekriteFaz 2
  • Mayo Clinic Building-Phoenix, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07007559

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Ap rekriteFaz 3
  • Mayo Clinic in Arizona - Phoenix, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Ap rekriteFaz 3
  • HonorHealth, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213804

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Ap rekriteFaz 2
  • Mayo Clinic Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07450859

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • Banner University Medical Center Phoenix, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Ap rekriteFaz 3
  • Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Ap rekriteFaz 1/2
  • Crinetics Study Site, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07129252

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
  • Investigative Site #132, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT06974110

Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer

Ap rekrite
  • Dignity Health, Phoenix
Laj 21 ak plis · Tout sèks · Mizajou May 12, 2026 · NCT06963723

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Ap rekriteEtid obsèvasyon
  • Mayo Clinic in Arizona, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Mar 12, 2026 · NCT06349642

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic, Phoenix
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2025 · NCT05394103

Etid Kansè Metastatik nan lòt vil

Lòt etid nan Phoenix

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.